The effect of dexamethasone on growth, mineral balance and bone mineralisation in preterm infants with chronic lung disease

European Journal of Pediatrics

Volumn 159, Issue 5, 2000, Pages 380-384

  Shrivastava, Anupam ^a,b   Lyon, Andrew ^b   McIntosh, Neil ^b  

^a SOUTHEND UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Chronic lung disease; Dexamethasone; Growth; Mineral balance; Preterm

Indexed keywords

DEXAMETHASONE;

ARTICLE; BODY GROWTH; CALCIUM METABOLISM; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DRUG EFFECT; FEMALE; HUMAN; INFANT; MALE; PREMATURITY; PRIORITY JOURNAL;

EID: 0034055340     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310051291     Document Type: Article

References (30)

1. 1. Avery GB, Fletcher AB, Kaplan M (1985) Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Pediatrics 75: 106-111
2. 2. Bancalari E, Abdenour GE, Feller R (1979) Bronchopulmonary dysplasia: clinical presentation. J Paediatr 85: 819-823
3. 3. Brownlee KG, Ng PC, Henderson HM, Smith M, Green JH, Dear PRF (1992) Catabolic effect of dexamethasone in the preterm baby. Arch Dis Child 67: 1-4
4. 4. Chesney RW, Hamstra AJ, Mazess RB, De Luca HF, O'Raegan S (1978) Reduction of serum 1,25dihydroxyvitamin D in children receiving glucocorticoids. Lancet 2: 1123-1125
5. 5. Chesney RW, Mazess RB, Rose P, Jax DK (1978) Effect of prednisone on growth and bone mineral content in childhood glomerular disease. Am J Dis Child 132: 768-772
6. 6. Co EC, Venkataraman PS, Shankararao R (1991) Effects of steroids on growth and bone mineralisation in the postnatal period (abstract). Pediatr Res 29: 58A
7. 7. Collaborative Dexamethasone Trial Group (1991) Dexamethasone therapy in neonatal chronic lung disease: an international placebo-controlled trial. Pediatrics 88: 421-427
8. 8. Cummings JJ, D'Eugenio DB, Gross SJ (1989) A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N Engl J Med 320: 1505-1510
9. 9. Crofton PM, Stirling HF, Schonau E, Ahmed SF, Wallace WHB, Wade JC, Magowan R, Shrivastava A, Lyon AJ, McIntosh N, Kelnar CJH (1996) Biochemical markers of bone turnover. Horm Res 45[Suppl 1]: 55-58
10. 10. Crofton PM, Stirling HF, Schonau E, Shrivastava A, Lyon AJ (1996) Collagen markers and bone alkaline phosphatase as predictors of bone turnover and growth. In: Schönau E (ed) Paediatric osteology: new developments in diagnostics and therapy, pp 241-250
11. 11. Fiske CH, Subbarow Y (1925) The colorimetric determination of phosphorus. J Biol Chem 66: 37-41
12. 12. Furman L, Hack M, Watts C, Borawaski-Clark E, Baley J, Amini S, Hook B (1995) Twenty-month outcome in ventilator-dependent, very low birth weight infants born during the early years of dexamethasone therapy. J Pediatr 126: 1424-1432
13. 13. Gibson AT, Pearse RG, Wales JKH (1993) Knemometry and assessment of growth in premature babies. Arch Dis Child 69: 498-504
14. 14. Gosling P (1986) Analytical reviews in clinical biochemistry: calcium measurement. Ann Clin Biochem 23: 145-156
15. 15. Greenough A (1990) Bronchopulmonary dysplasia: early diagnosis, prophylaxis and treatment. Arch Dis Child 65: 1082-1088
16. 16. Howard E, Benjamins JA (1975) DNA, ganglioside and sulfatide in brains of rats given corticosterone in infancy, with an estimate of cell loss during development. Brain Res 92: 73-87
17. 17. Hymes JS, Carey DE (1989) Corticosteroids and growth. Pediatrics 113: 249-254
18. 18. Jones R, Wincott E, Elbourne D, Grant A (1995) Controlled trial of dexamethasone in neonatal chronic lung disease: a 3-year follow-up. Pediatrics 96: 897-906
19. 19. Kimberg DV, Baerg RD, Gershon E, Graudusius RT (1971) Effect of cortisone treatment on the active transport of calcium by the small intestine. J Clin Invest 50: 1309-1321
20. 20. Lucas A (1998) Programming by early nutrition: an experimental approach. American Society for Nutritional Sciences 401s-406s
21. 21. Lyon AJ, McIntosh N (1984) Calcium and phosphorus balance in extremely low birth weight infants in the first six weeks of life. Arch Dis Child 59: 1145-1150
22. 22. Mitchell I, Barr DGD, Pocock SJ (1978) Catch-up growth in cortisone treated rats: effects of calcium and vitamin D. Pediatr Res 12: 1105-1110
23. 23. Morris HG (1975) Growth and skeletal maturation in asthmatic children: effect of corticosteroid treatment. Pediatr Res 9: 579-583
24. 24. Ng PC (1993) The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia. Arch Dis Child 68: 330-336
25. 25. Rickers H, Deding A, Christiansen C, Rodbro P, Nestoft J (1982) Corticosteroid induced osteopenia and vitamin D metabolism. Effect of vitamin D2, calcium phosphate and sodium fluoride administration. In: Norman AW, Schaefer K, Herrath DV, Grigoleit HG (eds) Vitamin D chemical, biochemical and clinical endocrinology of calcium metabolism. Walter de Gruyter, Berlin, pp 1027-1029
26. 26. Shapiro S (1968) Some physiological, biochemical and behavioural consequences of neonatal hormone administration: cortisol and thyroxine. Gen Comp Endocrinol 10: 214-228
27. 27. Weichsel ME (1977) The therapeutic use of glucocorticoid hormones in the perinatal period: potential neurologic hazards. Ann Neurol 2: 364-366
28. 28. Weiler HA, Paes B, Shah JK, Atkinson SA (1997) Longitudinal assessment of growth and bone mineral accretion in prematurely born infants treated for chronic lung disease with dexamethasone. Early Hum Dev 47: 271-286
29. 29. Weiler H, Zheng W, Atkinson S (1995) Dexamethasone treatment impairs calcium regulation and reduces bone mineralisation in infant pigs. Am J Clin Nutr 61: 805-811
30. 30. Williams JR, Davidson F, Menon G, McIntosh N (1994) A portable dual energy X-ray absorptiometry technique for the measurement of bone mineral in preterm infants. Pediatr Res 36: 351-357